Last Updated: November 13, 2026

LINCOMYCIN HYDROCHLORIDE Drug Patent Profile

« Back to Dashboard

Which patents cover Lincomycin Hydrochloride, and when can generic versions of Lincomycin Hydrochloride launch?

Lincomycin Hydrochloride is a drug marketed by Gland, Hainan Poly, Micro Labs, Quagen, Slayback, and Xgen Pharms. and is included in six NDAs.

The generic ingredient in LINCOMYCIN HYDROCHLORIDE is lincomycin hydrochloride. Nine suppliers are listed for this compound. Additional details are available on the lincomycin hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Lincomycin Hydrochloride

A generic version of LINCOMYCIN HYDROCHLORIDE was approved as lincomycin hydrochloride by XGEN PHARMS on June 4^th, 2015.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for LINCOMYCIN HYDROCHLORIDE?
What are the global sales for LINCOMYCIN HYDROCHLORIDE?
What is Average Wholesale Price for LINCOMYCIN HYDROCHLORIDE?

Summary for LINCOMYCIN HYDROCHLORIDE

US Patents:	0
Applicants:	6
NDAs:	6

US Patents and Regulatory Information for LINCOMYCIN HYDROCHLORIDE

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Gland	LINCOMYCIN HYDROCHLORIDE	lincomycin hydrochloride	INJECTABLE;INJECTION	215657-001	Sep 26, 2022	AP	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Quagen	LINCOMYCIN HYDROCHLORIDE	lincomycin hydrochloride	INJECTABLE;INJECTION	212770-001	Mar 12, 2021	AP	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Hainan Poly	LINCOMYCIN HYDROCHLORIDE	lincomycin hydrochloride	INJECTABLE;INJECTION	216662-001	Dec 21, 2022	AP	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.